News
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: ELARIS AG resolves to carry out a capital increase for cash from authorised capital with the exclusion of subscription rights in April 2024
ELARIS AG resolves to carry out a capital increase for cash from authorised capital in April 2024, issuing new shares at EUR 41.50 each to raise around EUR 3.5 million for growth financing -
-
COMMUNIQUÉ DE PRESSE
The National Anti-Corruption Commission Thailand seeks suitable measures to prevent corruption risks regarding rewards for officials to ensure transparency for all.
National Anti-Corruption Commission (NACC) of Thailand addresses concerns on bribery and rewards for officials to enhance transparency and confidence for local and international investors -
COMMUNIQUÉ DE PRESSE
Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada
Formycon and Fresenius Kabi reach settlement agreement with Johnson & Johnson for ustekinumab biosimilar FYB202 in Europe and Canada. Agreement terms kept confidential. Focus on expanding patient access and ensuring reliable treatment options -
COMMUNIQUÉ DE PRESSE
ESPG bond: More than 50% of bondholders have registered for written voting procedure – voting period is LIVE as of now
ESPG bondholders show strong participation in written voting procedure, aiming to reach quorum. Voting period now live with key decisions to be made, encouraging all to exercise their voting rights -
-
